These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25530333)

  • 1. Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand.
    Gane E; Stedman C; Brunton C; Radke S; Henderson C; Estes C; Razavi H
    N Z Med J; 2014 Dec; 127(1407):61-74. PubMed ID: 25530333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
    Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
    J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
    Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
    Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimates on HCV disease burden worldwide - filling the gaps.
    Wedemeyer H; Dore GJ; Ward JW
    J Viral Hepat; 2015 Jan; 22 Suppl 1():1-5. PubMed ID: 25560838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted effects of treatment for HCV infection vary among European countries.
    Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P
    Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C in the Czech Republic: Forecasting the disease burden.
    Fraňková S; Urbánek P; Husa P; Němeček V; Razavi H; Razavi-Shearer D; Chlíbek R; Šperl J
    Cent Eur J Public Health; 2019 Jun; 27(2):93-98. PubMed ID: 31241282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
    Willemse SB; Razavi-Shearer D; Zuure FR; Veldhuijzen IK; Croes EA; van der Meer AJ; van Santen DK; de Vree JM; de Knegt RJ; Zaaijer HL; Reesink HW; Prins M; Razavi H
    Neth J Med; 2015 Nov; 73(9):417-31. PubMed ID: 26582807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
    Dore GJ; Ward J; Thursz M
    J Viral Hepat; 2014 May; 21 Suppl 1():1-4. PubMed ID: 24713003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forecasting the disease burden of chronic hepatitis C virus in Poland.
    Flisiak R; Halota W; Tomasiewicz K; Kostrzewska K; Razavi HA; Gower EE
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):70-6. PubMed ID: 25426979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.
    Hatzakis A; Chulanov V; Gadano AC; Bergin C; Ben-Ari Z; Mossong J; Schréter I; Baatarkhuu O; Acharya S; Aho I; Anand AC; Andersson MI; Arendt V; Arkkila P; Barclay K; Bessone F; Blach S; Blokhina N; Brunton CR; Choudhuri G; Cisneros L; Croes EA; Dahgwahdorj YA; Dalgard O; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Estes C; Flisiak R; Gane E; Gower E; Halota W; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kershenobich D; Kostrzewska K; Kristian P; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Norris S; Nurmukhametova E; Nymadawa P; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prabdial-Sing N; Prins M; Radke S; Rakhmanova A; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Seguin-Devaux C; Shah SR; Shestakova I; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Puri P; Razavi H
    J Viral Hepat; 2015 Jan; 22 Suppl 1():26-45. PubMed ID: 25560840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.
    Aljumah AA; Abaalkhail F; Al-Ashgar H; Assiri A; Babatin M; Al Faleh F; Alghamdi A; Al-Hakeem R; Hashim A; Alqutub A; Razavi H; Sanai FM; Al-Swat K; Schmelzer J; Altraif I
    Saudi J Gastroenterol; 2016; 22(4):269-81. PubMed ID: 27488321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.
    Cramp ME; Rosenberg WM; Ryder SD; Blach S; Parkes J
    BMC Gastroenterol; 2014 Aug; 14():137. PubMed ID: 25100159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.
    Kwon JA; Dore GJ; Hajarizadeh B; Alavi M; Valerio H; Grebely J; Guy R; Gray RT
    PLoS One; 2021; 16(9):e0257369. PubMed ID: 34529711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
    Razavi H; Waked I; Sarrazin C; Myers RP; Idilman R; Calinas F; Vogel W; Mendes Correa MC; Hézode C; Lázaro P; Akarca U; Aleman S; Balık I; Berg T; Bihl F; Bilodeau M; Blasco AJ; Brandão Mello CE; Bruggmann P; Buti M; Calleja JL; Cheinquer H; Christensen PB; Clausen M; Coelho HS; Cramp ME; Dore GJ; Doss W; Duberg AS; El-Sayed MH; Ergör G; Esmat G; Falconer K; Félix J; Ferraz ML; Ferreira PR; Frankova S; García-Samaniego J; Gerstoft J; Giria JA; Gonçales FL; Gower E; Gschwantler M; Guimarães Pessôa M; Hindman SJ; Hofer H; Husa P; Kåberg M; Kaita KD; Kautz A; Kaymakoglu S; Krajden M; Krarup H; Laleman W; Lavanchy D; Marinho RT; Marotta P; Mauss S; Moreno C; Murphy K; Negro F; Nemecek V; Örmeci N; Øvrehus AL; Parkes J; Pasini K; Peltekian KM; Ramji A; Reis N; Roberts SK; Rosenberg WM; Roudot-Thoraval F; Ryder SD; Sarmento-Castro R; Semela D; Sherman M; Shiha GE; Sievert W; Sperl J; Stärkel P; Stauber RE; Thompson AJ; Urbanek P; Van Damme P; van Thiel I; Van Vlierberghe H; Vandijck D; Wedemeyer H; Weis N; Wiegand J; Yosry A; Zekry A; Cornberg M; Müllhaupt B; Estes C
    J Viral Hepat; 2014 May; 21 Suppl 1():34-59. PubMed ID: 24713005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios.
    Harris RJ; Thomas B; Griffiths J; Costella A; Chapman R; Ramsay M; De Angelis D; Harris HE
    J Hepatol; 2014 Sep; 61(3):530-7. PubMed ID: 24824282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of hepatitis C virus infection in Korea.
    Suh DJ; Jeong SH
    Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
    Durham DP; Skrip LA; Bruce RD; Vilarinho S; Elbasha EH; Galvani AP; Townsend JP
    Clin Infect Dis; 2016 Feb; 62(3):298-304. PubMed ID: 26628566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
    Lehman EM; Wilson ML
    J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.